4
Changes in Ownership
aTYR PHARMA INC Filed Acc 0001193125-26-009156
Options or other derivatives
- Chief Financial Officer acquired 412,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Broadfoot Jill Marie · Chief Financial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-01-09 | Grant or award : show line 1 in the form Employee Stock Option (right to buy) | +412,500 | 412,500 | D |
Loading xslF345X05/ownership.xml…